Hutchinson, J.H., Li, Y.W., Arruda, J.M., Baccei, C., Bain, G., Chapman, C., Correa, L., Darlington, J., King, C.D., Lee, C., Lorrain, D., Prodanovich, P., Rong, H.J., Santini, A., Stock, N., Prasit, P. and Evans, J.F. (2009) 5-Lipoxyge- nase-Activating Protein Inhibitors: Development of 3-[3-tert-Butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5- (pyri-din-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic Acid (AM103). Journal of Medicinal Chemistry, 52, 5803-5815.